TITLE

LABORATORY MARKERS PREDICT BONE LOSS IN CROHN'S DISEASE: RELATION TO PBMC FUNCTION AND NUTRITIONAL STATUS

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA106
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cohen's disease (CD) is associated with an increased prevalence of osteoporosis. Identification of surrogate markers for bone loss in CD may have resource implications. Researchers investigated the relation of simple markers of inflammation with markers of bone turnover, nutritional status, and cytokine production by peripheral blood mononuclear cells. Raised simple laboratory markers of inflammation, CRP and ESR, are associated with higher rates of bone loss in CD.
ACCESSION #
13219227

 

Related Articles

  • CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute Colitis. Wurbel, Marc-Andre; McIntire, Maria G.; Dwyer, Peter; Fiebiger, Edda // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Background & Aims: CCL25/CCR9 is a non-promiscuous chemokine/receptor pair and a key regulator of leukocyte migration to the small intestine. We investigated here whether CCL25/CCR9 interactions also play a role in the regulation of inflammatory responses in the large intestine. Methods: Acute...

  • Utilization of Health Care Resources by Individuals with Inflammatory Bowel Disease in the United States: A Profile of Time Since Diagnosis. Longobardi, Teresa; Jacobs, Phillip; Bernstein, Charles N. // American Journal of Gastroenterology;Apr2004, Vol. 99 Issue 4, p650 

    BACKGROUND: There are no cost studies of inflammatory bowel disease (IBD) that describe its impact on resource utilization or treatment costs over long periods of time. Our aim was to determine if there are observable trends in health-care resource utilization by adults with IBD depending on...

  • Prospective study of immunological factors in non-inflammatory bowel disease enterocutaneous fistulas. Rahbour, Goher; Hart, Ailsa L.; Al-Hassi, Hafid O.; Ullah, Mohammad R.; Gabe, Simon M.; Knight, Stella C.; Warusavitarne, Janindra; Vaizey, Carolynne J. // BMC Surgery;2011, Vol. 11 Issue 1, p12 

    Background: Enterocutaneous fistulas (ECF) are debilitating and usually result following complex abdominal surgery. While there is an association with inflammatory bowel disease (IBD), a large number of fistulas occur after surgery not related to IBD. The consequences of ECF include short bowel...

  • Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response? Wittig, B. M.; Zeitz, M. // International Journal of Colorectal Disease;Nov2006, Vol. 21 Issue 6, p505 

    Over the past several years, research in the field of cytokine production and function has become indispensable to understand the immunopathology of chronic intestinal inflammation. Thereupon, clinical studies analyzing cytokine production have generated a tremendous amount of data. In patients...

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 1, p21 

    The article discusses various research that explored the different aspects of inflammatory bowel disorders. One of the studies dealt with the changes in surgical resection rates and medical treatments for Crohn's disease. Another research focused on the association of pre-operative management...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Inflammatory bowel disease posters.  // Gut;Apr2005 Supplement 2, Vol. 54, pA89 

    The article presents information on abstracts related to inflammatory bowel disease. An abstract presents information on the faecal calprotectin in the management of IBD and in the assessment of patients with LBS. Calprotectin is a neutrophil derived protein that is stable in stool. It shows...

  • Neuroinflammation in inflammatory bowel disease. Lakhan, Shaheen E.; Kirchgessner, Annette // Journal of Neuroinflammation;2010, Vol. 7, p37 

    Inflammatory bowel disease is a chronic intestinal inflammatory condition, the pathology of which is incompletely understood. Gut inflammation causes significant changes in neurally controlled gut functions including cramping, abdominal pain, fecal urgency, and explosive diarrhea. These symptoms...

  • Inflammatory Bowel Disease Part II: Crohn's Disease - Pathophysiology and Conventional and Alternative Treatment Options. Head, Kathleen; Jurenka, Julie // Alternative Medicine Review;Dec2004, Vol. 9 Issue 4, p360 

    Crohn's disease, a subcategory of inflammatory bowel disease, contributes to significant morbidity, particularly in industrialized nations. It can affect people of any age, but is more commonly diagnosed in adolescence and young adulthood. Inflammation and ulceration occur primarily in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics